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What is already known about this subject
• In adults, associations between body mass index (BMI),
waist-to-height ratio (WHtR) and cardiometabolic
outcomes are similar.
• In children and adolescents, results from cross-sectional
studies examining the associations between BMI z scores,
WHtR and cardiometabolic outcomes are conﬂicting and
there is a paucity of prospective data.
What this study adds
• This is the ﬁrst study to demonstrate the prospective
association between WHtR in childhood and cardi-
ometabolic outcomes in adolescent boys.
• WHtR is a simple calculation that can be used to identify
children and adolescents for cardiometabolic risk without
the need for reference growth charts.
• The WHtR cut-point of ≥0.5 was highly speciﬁc in
identifying cardiometabolic risk co-occurrence but has
poor sensitivity.
Summary
Objective: To examine the associations between body mass index (BMI) and waist-to-height ratio (WHtR)
measured in childhood and adolescence and cardiometabolic risk factors in adolescence.
Methods: Secondary data analysis of the Avon Longitudinal Study of Parents and Children, a population
based cohort. Data from 2858 adolescents aged 15.5 (standard deviation 0.4) years and 2710 of these
participants as children aged 7–9 years were used in this analysis. Outcome measures were cardiometabolic
risk factors, including triglycerides, low density lipoprotein cholesterol, high density lipoprotein cholesterol,
insulin, glucose and blood pressure at 15 years of age.
Results: Both BMI and WHtR measured at ages 7–9 years and at age 15 years were associated with
cardiometabolic risk factors in adolescents. A WHtR ≥0.5 at 7–9 years increased the odds by 4.6 [95%
confidence interval 2.6 to 8.1] for males and 1.6 [0.7 to 3.9] for females of having three or more
cardiometabolic risk factors in adolescence. Cross-sectional analysis indicated that adolescents who had a
WHtR ≥0.5, the odds ratio of having three or more cardiometabolic risk factors was 6.8 [4.4 to 10.6] for males
and 3.8 [2.3 to 6.3] for females. The WHtR cut-point was highly specific in identifying cardiometabolic risk
co-occurrence in male children and adolescents as well as female children (90 to 95%), but had poor
sensitivity (17 to 53%). Similar associations were observed when BMI was used to define excess adiposity.
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Conclusions: WHtR is a simple alternative to age and sex adjusted BMI for assessing cardiometabolic
risk in adolescents.
Keywords: Waist-to-height ratio, cardiometabolic risk, ALSPAC longitudinal study.
Introduction
Obesity in childhood is associated with adverse
levels of cardiometabolic risk factors, including
higher blood pressure (BP), triglycerides, total and
low density lipoprotein cholesterol (LDLc) and insulin,
and lower high density lipoprotein cholesterol (HDLc)
(1–3). Furthermore, childhood obesity is positively
and linearly associated with obesity and related car-
diovascular disease in adulthood (4). It is important to
identify children who are at increased risk of devel-
oping comorbidities associated with obesity, to
potentially intervene and prevent the development of
chronic disease including type 2 diabetes.
We have previously reported, using data from the
Avon Longitudinal Study of Parents and Children
(ALSPAC), that childhood body mass index (BMI),
waist circumference and total fat mass are positively
associated with cardiovascular risk factors in adoles-
cence and the magnitudes of these associations are
similar for all measures of adiposity (2). There has
been recent interest in the use of the waist-to-height
ratio (WHtR) for identifying excessive central adipos-
ity in children and adolescents (5–8). It has been
suggested that a WHtR ≥0.5, irrespective of age, sex
or ethnicity (5,7,9), is a valid predictor of higher
cardiometabolic risk (10–12). WHtR may be a more
straightforward anthropometric index to apply in the
clinical setting where BMI centile charts may not be
readily available.
There have been two systematic reviews in adults
examining the associations between BMI and WHtR
and cardiometabolic outcomes which have indicated
broadly similar associations between the different
anthropometric measures and cardiometabolic risk
factors (7,13). However, the utility of WHtR in identi-
fying young people at cardiometabolic risk is unclear.
Results from cross-sectional studies are conflicting
some indicate that WHtR is more strongly associated
with cardiometabolic risk factors than BMI (10,12,14–
16), while others have found either a weaker (17) or a
similar (18,19) association. To our knowledge, there is
only one prospective study looking at this issue in
children and adolescents. That study reported similar
correlation between BMI and WHtR assessed in chil-
dren when they were aged 7 to 15 years and the
metabolic syndrome in young adulthood (20).
Therefore the aims of this study were to:
1. Examine the cross-sectional association
between WHtR and cardiometabolic risk factors in
adolescents.
2. Examine the prospective association between
WHtR assessed in childhood and cardiometabolic
risk factors assessed in adolescence.
3. Examine these associations in relevance to the
respective associations with BMI.
Methods
Participants
This study is a secondary analysis of data from the
ALSPAC (http://www.bristol.ac.uk/alspac). The
design and methods have been published (21). In
brief, ALSPAC is a longitudinal population-based
cohort that recruited 14 541 pregnant women who
were expected to deliver between 1 April 1991 and 31
December 1992 (21). All members of the ALSPAC
cohort were invited to annual follow-up clinics from
the age of 7 to 13 years and then approximately every
2 years thereafter. In addition, when the oldest chil-
dren were approximately 7 years of age, the sample
size was increased by inviting eligible cases who had
failed to join the study originally resulting in an addi-
tional 713 children being enrolled; 8297, 7725 and
5509 participants attended the 7-, 9- and 15-year
clinics, respectively. In the present study, baseline
‘childhood’ anthropometric data were taken from a
combination of the 7- and 9-year clinics.
If available, data from the 7-year clinic were used
preferentially (n = 2540) and data from an additional
168 children were used from the 9-year clinic.
Anthropometric and cardiometabolic risk factors
were taken from the 15-year clinic (n = 2858): the
‘adolescent’ group. The eligibility criteria for these
analyses were adolescents who had their waist cir-
cumference, height and serum lipid levels measured
at the 15 year clinic. There were no childhood
anthropometric measurements for 150 adolescents
who had both anthropometric and cardiometabolic
risk factors measured at the 15-year clinic; conse-
quently, data are missing for 5% (148 of 2858) of the
children. The final sample used in the analyses here
were 2858 adolescents (cross-sectional analysis) and
2710 children (prospective analysis). The majority
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(98%) of the mothers of the participants self-identified
their ethnicity as white. Ethical approval for the study
was obtained from the ALSPACEthics and LawCom-
mittee and the Local Research Ethics Committees.
Anthropometry
Standard protocols for assessing anthropometry
were used, with the participants in light clothing and
no shoes. Age was recorded in months. Weight was
measured to the nearest 0.1 kg using Tanita THF
300GS (Tanita UK Ltd, Yewsley, Middlesex, UK).
Height was measured using a Harpenden
stadiometer (Holtain Ltd, Crymych, Pembs, UK) to
the nearest 1 mm. Waist circumference was meas-
ured at the mid-point between the lower rib and the
iliac crest to the nearest 1 mm with a flexible tape
measure. Height, weight and BMI z scores were
determined using age and sex specific national ref-
erence values for the UK (22). WHtR was determined
by dividing waist circumference by height.
Cardiometabolic risk factors
The participants were requested to fast before
attending the 15-year clinic. For those attending
morning clinics they were asked to fast overnight.
For those attending afternoon clinics, they were
asked to fast for a minimum of 6 h prior to attend-
ance. Blood samples were taken from the cubital
fossa and immediately spun and plasma was frozen
at −80°C. Approximately 3 to 9 months later, the
samples were assayed. Total cholesterol, triglyceride
and HDLc concentrations were measured using a
modified Lipid Research Clinics Protocol with enzy-
matic reagents for lipid determination (2). LDLc was
determined with the Friedewald equation (23). An
automated assay was used to measure blood
glucose concentration. Insulin was measured using
an enzyme-linked immunosorbent assay (Mercodia,
Uppsala, Sweden) which does not cross react with
proinsulin. BP was measured using a Dinamap 9301
Vital Signs Monitor (Morton Medical, London, UK)
with appropriate cuff size. Each participant was at
rest and his/her arm was supported. For analysis, the
mean of the two measurements that were taken was
used.
Statistical analysis
Data were analysed using IBM SPSS Statistics 19.0
(IBM, Chicago, IL, USA) and MedCalc version 12.5.0
(Ostend, Belgium). The data were examined cross-
sectionally and prospectively and explored as con-
tinuous variables and as binary categorical variables.
Relationships between continuous variables were
examined by Spearman correlation coefficients. χ2
test was used as a measure of association between
categorical variables and odds ratios were used to
examine the strength of associations. The cut-points
used in this analysis to indicate cardiometabolic risk
were ≥1.7 mmol L−1 for triglycerides, < 1.03 mmol L−1
for HDLc, ≥ 5.6 mmol L−1 for plasma glucose,
≥ 130 mmHg for systolic BP, and ≥85 mmHg for
diastolic BP, as recommended by the International
Diabetes Federation for children and adolescents
(10 to 16 years) (24). The cut-points for LDLc and
insulin were ≥2.79 mmol L−1 and ≥16.95 IU L−1,
respectively, which is ≥90th centile for the cohort (2).
Cardiometabolic risk factor co-occurrence was
defined as having three or more cardiometabolic risk
factors using the binary outcome thresholds listed
above. Participants were classified as overweight or
obese based on sex- and age- specific International
Obesity Task Force (IOTF) BMI criteria (25) and ≥0.5
for WHtR (7). Receiver operator characteristic (ROC)
curves were used to identify the optimal WHtR cut-
points, sensitivity and specificity.
Results
The anthropometric characteristics of participants
are shown in Table 1. The prevalence of overweight
or obese was lower in childhood (13.8%; n = 375)
than in adolescence (17.2%; n = 490). The correla-
tion between BMI z scores in childhood and adoles-
cence was r = 0.72, P < 0.001, and 63.6% of
overweight and obese children remained overweight
or obese at 15 years. The proportion of participants
who had a high WHtR (≥0.5) was also lower in child-
hood (6.8%; n = 185) compared with adolescence
(17.2%; n = 492). The correlation between WHtR in
childhood and adolescence was r = 0.57, P < 0.001
and 69.2% of children with a high WHtR had a high
WHtR as adolescents.
BMI z scores and WHtR were highly correlated in
both childhood and adolescence: r = 0.80 and
r = 0.78 (both P < 0.001), respectively. The majority
(91.9%) of children with a high WHtR were also over-
weight or obese. Conversely, only 45.1% of over-
weight or obese children had a high WHtR. In
adolescence 72.0% of adolescents with a high
WHtR were overweight or obese, and 71.8% of over-
weight or obese adolescents had a high WHtR.
The prevalence of elevated cardiometabolic risk
factors in the adolescents varied from 2.2% (n = 62)
for high diastolic BP, to 29.0% (n = 806) with
high systolic BP, Table 2. In general, elevated
cardiometabolic risk factors were more common in
Waist-to-height ratio | 329
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
© 2013 The Authors. Pediatric Obesity published by John Wiley & Sons Ltd on behalf of International Association for the Study of
Obesity. Pediatric Obesity 9, 327–338
males than females, with approximately twice as
many males having low HDLc, high glucose levels
or high systolic BP compared to females. Co-
occurrence of three or more cardiometabolic risk
factors was more common in males than females.
Correlations were stronger between cardiometabolic
risk factors and anthropometric outcomes measured
in adolescence compared to those measured in
childhood, Table 3.
The proportions of overweight and obese adoles-
cents, or adolescents with a WHtR ≥0.5, that had
elevated LDLc, reduced HDLc, elevated glucose,
elevated insulin and/or high BP are shown in Table 4.
The odds ratios between measures of adiposity and
risk factors are shown in Fig. 1. Adolescent males
with WHtR ≥0.5 had an increased odds of elevated
triglycerides, LDLc, glucose, insulin and systolic BP
and low HDLc compared to males with a WHtR <0.5.
Furthermore, males with WHtR ≥0.5 had an
increased odds ratio of co-occurrence of
cardiometabolic risk factors compared to males with
a WHtR <0.5 (odds ratio = 6.8 [95% confidence
interval {CI} 4.4 to 10.6]). Overweight and obese
males had correspondingly increased odds of a
similar magnitude, compared with males who were
not overweight or obese. Females with a high WHtR
had increased odds ratio for elevated triglycerides,
LDLc, insulin and systolic BP and low HDLc, and
were approximately four times more likely (3.8 [2.3 to
6.3]) to have co-occurrence of cardiometabolic risk
factors than females with a WHtR <0.5. Overweight
and obese females had correspondingly increased
odds of the same cardiometabolic risk factors and
co-occurrence of these, (Fig. 1).
The specificity and sensitivity of a WHtR cut-point
of 0.5 in male adolescents for identifying
cardiometabolic risk factor co-occurrence was 90.0
(95% CI 88.2 to 91.6) and 41.3 (31.8 to 51.4),
respectively. For female adolescents the specificity
and sensitivity of a WHtR cut-point of 0.5 was 76.2
(73.7 to 78.2) and 53.1 (40.2 to 65.7). Using ROC
analysis the optimal WHtR cut point for identifying
co-occurrence of risk factors was 0.47 (specificity
83.5 [81.3 to 85.5]; sensitivity 51.9 [41.9 to 61.8]) for
Table 1 Anthropometric characteristics in childhood and adolescence. Results are expressed as median and
interquartile range unless otherwise indicated
Childhood Male Female Total
n n n
Age (months) 1317 89 [89, 90] 1393 89 [89, 90] 2710 89 [89, 90]
Height (cm) 1315 127.0 [123.1, 130.9] 1393 125.7 [122.0, 130.1] 2708 126.5 [122.5, 130.6]
Height z score 1315 0.38 [−0.36, 1.01] 1393 0.23 [−0.49, 0.90] 2708 0.28 [−0.42, 0.95]
Weight (kg) 1317 25.4 [23.2, 28.6] 1393 25.2 [22.8, 28.8] 2710 25.4 [23.0, 28.6]
Weight z score 1317 0.26 [−0.35, 0.94] 1393 0.15 [−0.45, 0.86] 2710 0.20 [−0.41, 0.90]
BMI 1315 15.77 [14.92, 16.88] 1393 15.94 [14.90, 17.40] 2708 15.87 [14.91, 17.14]
BMI z score 1315 0.08 [−0.54, 0.71] 1393 0.04 [−0.58, 0.76] 2708 0.06 [−0.57, 0.74]
Overweight and obese, n (%) 1315 149 (11.3) 1393 226 (16.2) 2708 375 (13.8)
WHtR* 1314 0.44 [0.43, 0.46] 1392 0.44 [0.42, 0.46] 2706 0.44 [0.42, 0.46]
WHtR* ≥0.5, n (%) 1314 82 (6.2) 1392 103 (7.4) 2706 185 (6.8)
Adolescence Male Female Total
n n n
Age (months) 1376 184 [183, 186] 1482 184 [183, 187] 2858 184 [183, 187]
Height (cm) 1376 174.9 [170.0, 180.0] 1482 164.6 [161, 168.7] 2858 169.0 [163.5, 175.5]
Height z score 1376 0.47 [−0.16, 1.10] 1482 0.29 [−0.32, 0.96] 2858 0.37 [−0.22, 1.03]
Weight (kg) 1375 62.6 [56.8, 69.7] 1477 57.4 [52.2, 63.8] 2852 60.1 [53.9, 66.8]
Weight z score 1375 0.46 [−0.10, 1.03] 1477 0.36 [−0.29, 1.04] 2852 0.42 [−0.19, 1.03]
BMI 1375 20.38 [8.90, 22.24] 1477 21.10 [19.41, 23.23] 2852 20.71 [19.12, 22.80]
BMI z score 1375 0.32 [−0.30, 0.98] 1477 0.34 [−0.32, 1.01] 2852 0.33 [−0.31, 0.99]
Overweight or obese, n (%) 223 (16.2) 267 (18.1) 490 (17.2)
WHtR* 1376 0.43 [0.41, 0.46] 1482 0.46 [0.43, 0.49] 2858 0.44 [0.41, 0.48]
WHtR* ≥0.5, n (%) 152 (11.0) 340 (22.9) 492 (17.2)
*Waist-to-height ratio.
BMI, body mass index; WHtR, waist-to-height ratio.
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male adolescents and 0.48 (specificity 65.8 [63.3
to 68.3]; sensitivity 67.2 [54.3 to 78.4] for female
adolescents.
The proportions of overweight and obese children
or those with a WHtR ≥0.5 who had elevated LDLc,
reduced HDLc, elevated glucose, elevated insulin
and/or high BP during adolescence are shown in
Table 5. Like the cross-sectional analysis, male chil-
drenwho had aWHtR ≥ 0.05 or whowere overweight
or obese had increased odds of cardiometabolic risk
factors in adolescence, Fig. 2. However, the CIs
around the odds ratio tended to be wider. Male chil-
dren with WHtR ≥0.5 had approximately five times
higher probability (4.6 [2.6 to 8.1]) of co-occurrence of
risk factors during adolescence than male children
with a WHtR <0.5. Overweight and obese male chil-
dren had approximately four times higher probability
(3.6 [2.2 to 5.8]) of co-occurrence of risk factors
during adolescence. Similar associations between
both anthropometric measures and cardiometabolic
risk factors were also observed in female children,
although the odds ratios were generally small, and the
lower limits of the CIs below one, Fig. 2.
The specificity and sensitivity of aWHtR cut-point of
0.5 inmale children for identifying cardiometabolic risk
factor co-occurrence in adolescents was 94.7 (93.3
to 95.9) and 21.1 (13.4 to 30.6), respectively. For
female children the specificity and sensitivity of a
WHtR cut-point of 0.5 was 91.4 (89.8 to 92.9) and
17.0 (8.1 to 29.8). Using ROC analysis the optimal
WHtR cut point for identifying co-occurrence of risk
factors inmale childrenwas the same as it was inmale
adolescents 0.47 (specificity 83.3 [81.0 to 85.3]; sen-
sitivity 37.9 [28.1 to 48.4]), but lower in female children
compared to female adolescents 0.44 (specificity
54.4 [51.7 to 57.1]; sensitivity 71.7 [57.7 to 83.2]).
Discussion
To our knowledge this is the first study to demon-
strate a prospective association between having a
high WHtR in childhood and cardiometabolic risk
co-occurrence in adolescent boys. The results dem-
onstrate that the of risk for having a WHtR ≥0.5 was
comparable to being overweight or obese as defined
by sex- and age- specific IOTF BMI criteria. For
example, children with a WHtR ≥0.5, had two to
five times higher odds of cardiometabolic risk
co-occurrence compared to children who had a
WHtR <0.5 and children who were overweight or
obese had two to four times higher odds compared
to normal weight children. However, there was
a sex difference and the association between
anthropometric measures in childhood and
Table 2 Biochemistry and blood pressure in adolescence. Data are expressed as median [interquartile range] and the
number (%) above cut-points, or below cut-point for HDLc
Male Female Total P†
n n n
Triglycerides
(mmol L−1)
1376 0.73 [0.57, 0.96] 1482 0.77 [0.62, 0.99] 2858 0.75 [0.59, 0.98]
≥1.7 mmol L−1 43 (3.1) 43 (2.9) 86 (3.0) 0.727
LDLc (mmol L−1) 1376 1.94 [1.62, 2.30] 1482 2.12 [1.79, 2.52] 2858 2.03 [1.70, 2.41]
≥2.79 mmol L−1 104 (7.6) 221 (14.9) 325 (11.4) <0.001
HDLc (mmol L−1) 1376 1.20 [1.01, 1.38] 1482 1.33 [1.16, 1.54] 2858 1.27 [1.09, 1.47]
<1.03 mmol L−1 347 (25.2) 178 (12.0) 525 (18.4) <0.001
Glucose (mmol L−1) 1376 5.3 [5.0, 5.5] 1482 5.1 [4.9, 5.3] 2858 5.2 [5.0, 5.4]
≥5.6 mmol L−1 313 (22.7) 159 (10.7) 472 (16.5) 0.004
Insulin (IU L−1) 1374 8.17 [6.00, 11.16] 1480 9.65 [7.25, 12.76] 2854 8.97 [6.63, 12.05]
≥16.95 IU L−1 102 (7.4) 155 (10.5) 257 (9.0) <0.001
Systolic BP (mmHg) 1335 126.5 [119.0, 133.5] 1444 120.5 [113.0, 127.5] 2779 123.5 [115.5, 131.0]
≥130 mmHg 517 (38.7) 289 (20.0) 806 (29.0) <0.001
Diastolic BP (mmHg) 1335 66.5 [60.5, 73.5] 1444 66.0 [60.5, 71.0] 2779 66.0 [60.5, 72.0]
≥85 mmHg 40 (3.0) 22 (1.5) 62 (2.2) 0.009
Risk co-occurrence* 104 (7.6) 64 (4.3) 168 (5.9) <0.001
*Risk co-occurrence is the presence of ≥3 of the following: triglycerides ≥1.7 mmol L−1, LDLc ≥2.79 mmol L−1, HDLc <1.03 mmol L−1, plasma glucose
≥5.6 mmol L−1, insulin ≥16.95 IU L−1, systolic blood pressure ≥130 mmHg, or diastolic blood pressure ≥85 mmHg.
†Pearson χ2.
BP, blood pressure; HDLc, high density lipoprotein cholesterol; LDLc, low density lipoprotein cholesterol.
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cardiometabolic risk co-occurrence in adolescence
was significantly stronger in boys than girls. In the
clinical environment, using a WHtR cut-point of 0.5
has several advantages over defining a child as over-
weight or obese by BMI; it is a simpler index to
calculate, easily understood by adolescents and
families and does not require sex- and age- specific
centiles.
The findings of this study are broadly consistent
with another prospective study that examined corre-
lations between BMI and WHtR in Australian children
and adult cardiometabolic risk factors (20). While
direct comparisons between studies is difficult, it is
interesting to note that the correlations between
WHtR and BMI measured at 7 to 11 years with
triglycerides (rho = 0.07 and 0.05 for WHtR and BMI,
respectively) and insulin (rho = 0.11 for both WHtR
and BMI) measured in adulthood were of a similar
magnitude to what we report between WHtR and
BMI measured at 7 to 9 years and triglycerides
and insulin measured in adolescence.
The association between WHtR and cardi-
ometabolic risk, both measured in adolescence,
support a number of other cross-sectional studies
(26,27), which have been recently reviewed (7). In
general, all studies showed good agreement in the
magnitude and outcome of their analysis between
WHtR and BMI and outcomes of cardiometabolic
risk. Consistent with our study, both WHtR and
BMI had a stronger association with triglycerides
and HDLc, than LDLc. The association between
anthropometric measures and BP tended to be
stronger for systolic BP compared to diastolic BP
and both WHtR and BMI were associated
with fasting insulin and a ‘cardiometabolic risk
score’, albeit defined differently among the different
studies.
There is no consensus on the cross-sectional
association of WHtR and BMI and fasting glucose
(3,15,17). In part, this may be explained by the dif-
fering age of the cohorts (range from 4 to 17 years)
and methods of analysing the data. Findings from
our study suggest that adolescent males with a high
WHtR or who are overweight or obese have an
increased risk of an elevated fasting glucose.
However, it is of note that in our study a high
proportion of adolescents (23% of males; 11%
of females) had fasting blood glucose levels
≥5.6mmol L−1. In the absence of evidence to indicate
that this population has disturbances in glucose
metabolism, these findings could reflect the diurnal
variation in blood glucose (28), since some adoles-
cents had blood taken in the afternoon after a 6 h
fast and/or inadequate fasting. The results pertainingTa
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to fasting glucose in this study need to be interpreted
with caution.
More children were classified as overweight or
obese using BMI criteria compared to those classi-
fied as having a high WHtR. Children with a WHtR
≥0.5 were more severely obese compared to chil-
dren were defined as overweight or obese using BMI
criteria, mean ± standard deviation BMI z-score was
2.05 ± 0.9 and 1.82 ± 0.9, respectively. The most
appropriate cut-point for WHtR to identify children
and adolescents at cardiometabolic risk is not clear.
In the present study we used ≥0.5 which has dem-
onstrated utility in adults (7) and children (10) but
other cut-points have been suggested (8). Our
results indicated that a cut-point ≥0.5 was highly
specific in identifying cardiometabolic risk co-
occurrence in male children and adolescents as
well as female children (90 to 95%), but had poor
sensitivity (17 to 53%); the risk of being wrongly
labelled as having co-occurrence of cardiometabolic
risk factors was small, but many of those who were
at risk were not identified. Statistically optimum cut-
points were identified as 0.47 for male children and
male adolescents and 0.44 and 0.48 for female chil-
dren and female adolescents, respectively. However,
by increasing the sensitivity, the specificity
decreased particularly for female children (from 91
to 54%); using lower cut-points more children and
adolescents would be incorrectly labelled as being
as having co-occurrence of cardiometabolic risk
factors. Given the stigma of being incorrectly
labelled and the limited resources for managing chil-
dren and adolescents at cardiometabolic risk it
could be prudent to use a higher but more specific
cut-point.
There are a number of limitations to the study
including the number of participants which had com-
plete data. Initially over 14 000 pregnant women
Male
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0.1 1 10 100
Triglycerides 
LDLc
HDLc
Glucose
Insulin
Systolic BP
Diastolic BP 
Risk co-occurrenceb
Triglycerides 
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Figure 1 Odds ratio (95%CI) for
risk factors associated with over-
weight and obesity defined by BMI
(symbol: black triangle) andWHtR of
≥0.5 (symbol: white triangle) in ado-
lescents (cross-sectional analysis).
Risk factors were defined as
follows: triglycerides ≥1.7 mmol/L,
LDLc ≥ 2.79 mmol/L, HDLc <
1.03 mmol/L, plasma glucose
≥5.6 mmol/L, insulin ≥16.95 IU/L,
systolic blood pressure
≥130 mmHg, or diastolic blood
pressure ≥85 mmHg. bRisk co-
occurrence was defined as ≥3 of
the above.
334 | L. Graves et al.
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
© 2013 The Authors. Pediatric Obesity published by John Wiley & Sons Ltd on behalf of International Association for the Study of
Obesity. Pediatric Obesity 9, 327–338
Ta
b
le
5
Th
e
pr
op
or
tio
n
of
ad
ol
es
ce
nt
s
w
ith
ca
rd
io
m
et
ab
ol
ic
ris
k
fa
ct
or
s,
st
ra
tif
ie
d
by
se
x
an
d
an
th
ro
po
m
et
ric
st
at
us
in
ch
ild
ho
od
(p
ro
sp
ec
tiv
e
an
al
ys
is
)
O
ut
co
m
e
an
d
ex
p
os
ur
e
M
al
e
Fe
m
al
e
%
w
ith
in
cr
ea
se
d
ad
ip
os
ity
*
an
d
ris
k
fa
ct
or
/s
%
w
ith
ou
t
in
cr
ea
se
d
ad
ip
os
ity
*
an
d
w
ith
ris
k
fa
ct
or
/s
P
†
%
w
ith
in
cr
ea
se
d
ad
ip
os
ity
*
an
d
ris
k
fa
ct
or
/s
%
w
ith
ou
t
in
cr
ea
se
d
ad
ip
os
ity
*
an
d
w
ith
ris
k
fa
ct
or
/s
P
†
Tr
ig
ly
ce
rid
es
(≥
1.
7
m
m
ol
L−
1 )
B
M
I
6.
7
2.
3
0.
00
2
1.
3
2.
9
0.
17
W
H
tR
11
.0
2.
3
<0
.0
01
1.
0
2.
8
0.
27
LD
Lc
(≥
2.
79
m
m
ol
L−
1 )
B
M
I
10
.0
7.
2
0.
22
17
.0
14
.2
0.
58
W
H
tR
11
.0
7.
3
0.
22
16
.5
14
.5
0.
58
H
D
Lc
(<
1.
03
m
m
ol
L−
1 )
B
M
I
40
.7
23
.6
<0
.0
01
16
.6
10
.8
0.
02
W
H
tR
42
.7
24
.4
<0
.0
01
16
.5
11
.4
0.
12
G
lu
co
se
(≥
5.
6
m
m
ol
L−
1 )
B
M
I
24
.7
22
.5
0.
50
10
.4
9.
6
0.
92
W
H
tR
28
.0
22
.3
0.
23
11
.7
10
.2
0.
63
In
su
lin
(≥
16
.9
5
IU
L−
1 )
B
M
I
16
.1
5.
8
<0
.0
01
14
.5
8.
3
0.
00
1
W
H
tR
19
.8
6.
2
<0
.0
01
13
.7
9.
0
0.
22
S
ys
to
lic
B
P
(≥
13
0
m
m
H
g)
B
M
I
53
.1
36
.9
<0
.0
01
27
.5
18
.9
0.
00
6
W
H
tR
57
.0
37
.5
0.
00
1
25
.3
19
.9
0.
13
D
ia
st
ol
ic
B
P
(≥
85
m
m
H
g)
B
M
I
3.
4
2.
9
0.
71
1.
8
1.
4
0.
65
W
H
tR
3.
8
2.
9
0.
66
1.
0
1.
5
0.
69
R
is
k
co
-o
cc
ur
re
nc
e‡
B
M
I
18
.1
6.
1
<0
.0
01
6.
3
3.
4
0.
04
W
H
tR
24
.4
6.
4
<0
.0
01
6.
1
3.
7
0.
27
*B
M
Iw
as
ca
te
go
riz
ed
as
ov
er
w
ei
gh
t/
ob
es
e
or
no
t
ov
er
w
ei
gh
t/
ob
es
e
an
d
W
H
tR
w
as
ca
te
go
riz
ed
as
<0
.5
or
≥0
.5
.
† χ
2
(P
ea
rs
on
).
‡ R
is
k
co
-o
cc
ur
re
nc
e
is
th
e
pr
es
en
ce
of
≥3
of
th
e
fo
llo
w
in
g:
tr
ig
ly
ce
rid
es
≥1
.7
m
m
ol
L−
1 ,
LD
Lc
≥2
.7
9
m
m
ol
L−
1 ,
H
D
Lc
<1
.0
3
m
m
ol
L−
1 ,
pl
as
m
a
gl
uc
os
e
≥5
.6
m
m
ol
L−
1 ,
in
su
lin
≥1
6.
95
IU
L−
1 ,
sy
st
ol
ic
bl
oo
d
pr
es
su
re
≥1
30
m
m
H
g,
or
di
as
to
lic
bl
oo
d
pr
es
su
re
≥8
5
m
m
H
g.
B
M
I,
bo
dy
m
as
s
in
de
x;
B
P,
bl
oo
d
pr
es
su
re
;
H
D
Lc
,
hi
gh
de
ns
ity
lip
op
ro
te
in
ch
ol
es
te
ro
l;
LD
Lc
,
lo
w
de
ns
ity
lip
op
ro
te
in
ch
ol
es
te
ro
l;
W
H
tR
,
w
ai
st
-t
o-
he
ig
ht
ra
tio
.
Waist-to-height ratio | 335
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
© 2013 The Authors. Pediatric Obesity published by John Wiley & Sons Ltd on behalf of International Association for the Study of
Obesity. Pediatric Obesity 9, 327–338
were recruited, with over 5500 participants attending
the 15 years clinic, yet only 2710 met our inclusion
criteria for our prospective analysis and 2858 for our
cross-sectional analysis. The implications of attrition
are not clear and may affect the generalizability of the
findings. Nevertheless, this is the largest study in
children and adolescents addressing the association
between WHtR and cardiometabolic risk factors, as
well as the first in the UK.
Another potential limitation relates to measuring
waist circumference and applies to both the location
of the measurement and sensitivity around measur-
ing waist circumference in heavier children. There is
no universally accepted method of measuring waist
circumference. In this study the waist circumference
was measured at the mid-point between the lowest
rib and the iliac crest, which has been demonstrated
to be reproducible and highly correlated with total
body and trunk adiposity (29). It is recognized that
removal of clothing and placement of the measuring
tape may be awkward or embarrassing for the over-
weight or obese children and needs to be handled
sensitively.
In conclusion, we found that BMI z scores and
WHtR were highly correlated and that they have
similar associations with cross-sectional and pro-
spective cardiometabolic risk factors in adolescence.
WHtR is a simple calculation that could be used
to identify male children and adolescents for
cardiometabolic risk.
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Figure 2 Odds ratio (95% confi-
dence interval) for risk factors asso-
ciated with overweight and obesity
defined by body mass index
(▲) and waist-to-height ratio of ≥0.5
(▽) in childhood (prospective analy-
sis). Risk factors were defined as
follows: triglycerides ≥1.7 mmol/L,
low density lipoprotein cholesterol
(LDLc) ≥2.79 mmol/L, high density
lipoprotein cholesterol (HDLc)
<1.03 mmol/L, plasma glucose
≥5.6 mmol/L, insulin ≥16.95 IU/L,
systolic blood pressure (BP). bRisk
co-occurrence was defined as ≥3 of
the above.
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